{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:30:13Z","timestamp":1789695013284,"version":"4.0.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The differential diagnosis of diabetes insipidus is challenging. The most reliable approaches are copeptin measurements after hypertonic saline infusion or arginine, which is a known growth hormone secretagogue but has recently also been shown to stimulate the neurohypophysis. Similar to arginine, glucagon stimulates growth hormone release, but its effect on the neurohypophysis is poorly studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Double-blind, randomized, placebo-controlled trial including 22 healthy participants, 10 patients with central diabetes insipidus, and 10 patients with primary polydipsia at the University Hospital Basel, Switzerland.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Each participant underwent the glucagon test (s.c. injection of 1 mg glucagon) and placebo test. The primary objective was to determine whether glucagon stimulates copeptin and to explore whether the copeptin response differentiates between diabetes insipidus and primary polydipsia. Copeptin levels were measured at baseline, 30, 60, 90, 120, 150, and 180 min after injection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In healthy participants, glucagon stimulated copeptin with a median increase of 7.56 (2.38; 28.03) pmol\/L, while placebo had no effect (0.10 pmol\/L (\u22120.70; 0.68); P &amp;lt; 0.001). In patients with diabetes insipidus, copeptin showed no relevant increase upon glucagon, with an increase of 0.55 (0.21; 1.65) pmol\/L, whereas copeptin was stimulated in patients with primary polydipsia with an increase of 15.70 (5.99; 24.39) pmol\/L. Using a copeptin cut-off level of 4.6pmol\/L had a sensitivity of 100% (95% CI: 100\u2013100) and a specificity of 90% (95% CI: 70\u2013100) to discriminate between diabetes insipidus and primary polydipsia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Glucagon stimulates the neurohypophysis, and glucagon-stimulated copeptin has the potential for a safe, novel, and precise test in the differential diagnosis of diabetes insipidus.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1530\/eje-22-0033","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T10:39:22Z","timestamp":1651833562000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":47,"title":["Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-7304","authenticated-orcid":false,"given":"Cihan","family":"Atila","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, University of Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Gaisl","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, University of Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R","family":"Vogt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, University of Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Werlen","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University Hospital Basel, University of Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Szinnai","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetology, University Children's Hospital Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-0965","authenticated-orcid":false,"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, University of Basel , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"2023010809165960400_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.beem.2016.02.007","article-title":"Diabetes insipidus: differential diagnosis and management","volume":"30","author":"Robertson","year":"2016","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/imj.13627","article-title":"Polyuria-polydipsia syndrome: a diagnostic challenge","volume":"48","author":"Nigro","year":"2018","journal-title":"Internal Medicine Journal"},{"key":"2023010809165960400_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/jc.2010-2345","article-title":"Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome \u2013 revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clinical Chemistry"},{"key":"2023010809165960400_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"2023010809165960400_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(19)31255-3","article-title":"Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study","volume":"394","author":"Winzeler","year":"2019","journal-title":"Lancet"},{"key":"2023010809165960400_bib8","doi-asserted-by":"crossref","first-page":"w20237","DOI":"10.4414\/smw.2020.20237","article-title":"Copeptin-based diagnosis of diabetes insipidus","volume":"150","author":"Refardt","year":"2020","journal-title":"Swiss Medical Weekly"},{"key":"2023010809165960400_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-31-2-222","article-title":"Glucagon stimulation of human growth hormone","volume":"31","author":"Cain","year":"1970","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib10","doi-asserted-by":"crossref","first-page":"608056","DOI":"10.5402\/2011\/608056","article-title":"Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives","volume":"2011","author":"Yuen","year":"2011","journal-title":"ISRN Endocrinology"},{"key":"2023010809165960400_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12020-015-0783-7","article-title":"Copeptin under glucagon stimulation","volume":"52","author":"Lewandowski","year":"2016","journal-title":"Endocrine"},{"key":"2023010809165960400_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","article-title":"The assessment of growth hormone status in normal young adult males using a variety of provocative agents","volume":"45","author":"Rahim","year":"1996","journal-title":"Clinical Endocrinology"},{"key":"2023010809165960400_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/JOE-08-0290","article-title":"Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes","volume":"199","author":"Quesada","year":"2008","journal-title":"Journal of Endocrinology"},{"key":"2023010809165960400_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.2001.01169.x","article-title":"An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease","volume":"54","author":"Leong","year":"2001","journal-title":"Clinical Endocrinology"},{"key":"2023010809165960400_bib15","first-page":"608","article-title":"Advances in differential diagnosis and management of growth hormone deficiency in children","volume":"17","author":"Hage","year":"2021","journal-title":"Nature Reviews: Endocrinology"},{"key":"2023010809165960400_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1507\/endocrj.EJ18-0147","article-title":"Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis","volume":"65","author":"Ach","year":"2018","journal-title":"Endocrine Journal"},{"key":"2023010809165960400_bib17","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2265.1998.00610.x","article-title":"Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST)","volume":"49","author":"Orme","year":"1998","journal-title":"Clinical Endocrinology"},{"key":"2023010809165960400_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0026-0495(75)90093-1","article-title":"The effect of glucose on the growth hormone response to glucagon and propranolol-glucagon in normal subjects","volume":"24","author":"Sawin","year":"1975","journal-title":"Metabolism: Clinical and Experimental"},{"key":"2023010809165960400_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-30-5-619","article-title":"Hypoglycemic threshold for human growth hormone release","volume":"30","author":"Glick","year":"1970","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165960400_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000497214","article-title":"Growth hormone response to oral glucose load: from normal to pathological conditions","volume":"108","author":"Hage","year":"2019","journal-title":"Neuroendocrinology"},{"key":"2023010809165960400_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(87)91577-0","article-title":"Somatostatin centrally inhibits vasopressin secretion during haemorrhage","volume":"436","author":"Wang","year":"1987","journal-title":"Brain Research"},{"key":"2023010809165960400_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0016-5085(88)80020-9","article-title":"Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide","volume":"95","author":"Feldman","year":"1988","journal-title":"Gastroenterology"},{"key":"2023010809165960400_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/jcem-71-5-1269","article-title":"Vasopressin and oxytocin responses to illusory self-motion and nausea in man","volume":"71","author":"Koch","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/1\/EJE-22-0033.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/65\/48516245\/eje-22-0033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/65\/48516245\/eje-22-0033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:17:51Z","timestamp":1676391471000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/1\/65\/6972128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-22-0033","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,5,12]]}}}